JNJ vs SLB: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and Slb N.V. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Johnson & Johnson · Healthcare
$270.68
+5.7% upside to fair value
Med Conviction
Grade C
High Quality
VS
Slb N.V. · Energy
$52.08
+8.6% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
SLB has more upside to fair value
(+8.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JNJ |
SLB |
| Current Price |
$270.68 |
$52.08 |
| Fair Value Estimate |
$286.05 |
$56.56 |
| Upside to Fair Value |
+5.7%
|
+8.6%
|
| Market Cap |
$652.3B |
$77.3B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
20.2x
|
12.2x
|
| Price / Sales |
6.7x
|
2.1x
|
| Price / FCF |
35.3x
|
17.1x
|
| Revenue Growth YoY |
+6.6%
|
+5.0%
|
| Gross Margin |
67.9%
|
16.5%
|
| Operating Margin |
26.8%
|
13.4%
|
| Return on Equity |
25.7%
|
11.8%
|
| Dividend Yield |
1.95% |
2.25% |
| FCF Yield |
2.83%
|
5.83%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:…
SLB N.V. is the world's largest oilfield services provider, operating four divisions (Digital & Integration, Reservoir Performance, Well Construction, and Production Systems) that span field development, drilling, subsea production, and carbon management for the global energy industry. The business carries a medium-quality profile: it benefits from deep technical expertise, a broad international …
Accumulation Zones
| Metric |
JNJ |
SLB |
| Zone Low |
$214.54 |
$42.42 |
| Zone High |
$243.14 |
$48.08 |
| In Buy Zone? |
No
|
No
|